Countries China
I-Mab Reports Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab
Encouraging efficacy signals were observed in a non-small cell lung cancer (NSCLC) patient cohort - Results indicate CD73 expression corr...
May 27, 2022 | News
SeekIn Receives CE Mark Approval for SeekInClarity™ Cancer Treatment Response Monitoring Kit
SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (ConformitéEuropéenne) Mark approval...
May 26, 2022 | News
New Horizon Health Partners with Prenetics in Hong Kong to Launch ColoClear, a Non-Invasive Stool DNA Test to Detect Colon Cancer
New Horizon Health and Prenetics will jointly promote ColoClear in Hong Kong, Macau and Taiwan, with additional options to expand the p...
May 24, 2022 | News
INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China
INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment...
May 17, 2022 | News
Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases
The planned Phase 1 study is a double-blind, randomized, placebo-controlled, single and multiple dose escalation study in healthy subjects. The study aims ...
May 16, 2022 | News
Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines
The 2022 CSCO Guidelines incorporate a total of four selinexor combination therapy regimens for relapsed myeloma. In addition, the guidelines also recommen...
May 13, 2022 | News
Biocytogen Enters into Antibody Agreement with Merck
Under the agreement, Biocytogen will provide Merck antibodies directed against at least three targets specified by them from Biocytogen's Project Integrum&...
May 02, 2022 | News
WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability
One example of WuXi Biologics' contribution to society is its rapid, robust pandemic response -- enabling nearly 30 Investigational New Drug Applications (...
April 28, 2022 | News
SonoScape S-Fetus 4.0 Release to Simplify Sonography Process
Leveraging the deep learning techniques, the S-Fetus 4.0 Obstetric Screening Assistant allows doctors to automatically acquire standard planes and measure ...
April 27, 2022 | News
Porton Advanced and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Cell Therapy Development for Solid Tumors
Porton Advanced offers an end-to-end gene and cell therapy CDMO service platform covering plasmids, cell therapy, gene therapy, oncolytic virus, mRNA thera...
April 26, 2022 | News
Lynk Pharmaceuticals Announces Clinical Approval in China for Its Class I New Drug LNK01004
LNK01004 is a novel kinase inhibitor that can simultaneously inhibit multiple inflammatory cytokines and block multiple signaling pathways related to psori...
April 25, 2022 | News
GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate
Aimed Bio, a spin-off company from Samsung Medical Center, is focusing on developing innovative antibody-centric drugs for brain diseases with few treatmen...
April 19, 2022 | News
SonoScape receives FDA 510(k) clearance for HD-550 Endoscopy system
Paired with a 4-LED light source, which supports 1080P high definition, the HD-550 endoscopy system enables multi-spectrum and multi-mode. Adding to the hi...
April 18, 2022 | News
CR Pharma intends to make strategic equity investment for Everest's mRNA technology platform
Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancemen...
April 07, 2022 | News
Most Read
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
